Provided by Tiger Trade Technology Pte. Ltd.

SILO PHARMA INC.

1.46
-0.0420-2.80%
Post-market: 1.21-0.2479-17.00%19:59 EDT
Volume:1.15M
Turnover:1.74M
Market Cap:2.56M
PE:-0.29
High:1.57
Open:1.50
Low:1.45
Close:1.50
52wk High:10.87
52wk Low:1.45
Shares:1.75M
Float Shares:1.52M
Volume Ratio:17.81
T/O Rate:75.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0667
EPS(LYR):-7.5654
ROE:-91.23%
ROA:-44.25%
PB:0.52
PE(LYR):-0.19

Loading ...

Silo Pharma Prices USD 4 Million At-the-market Private Placement of 619,965 Shares

Reuters
·
Jul 10

Silo Pharma Issues Series A-3 and A-4 Warrants Exercisable at $6.21 Per Share

Reuters
·
Jul 10

Silo Pharma - Expects $4 Mln Gross Proceeds from Offering Before Fees

THOMSON REUTERS
·
Jul 10

Silo Pharma Announces up to $11.7 Million Private Placement Priced At-the-market Under NASDAQ Rules

THOMSON REUTERS
·
Jul 10

Silo Pharma Subsidiary Qwikagents Joins Nvidia Developer Program

Reuters
·
Jul 07

Silo Pharma Subsidiary Qwikagents Set to Advance Enterprise AI Agent Platform Through Nvidia Developer Program

THOMSON REUTERS
·
Jul 07

Silo Pharma engages Resyca to conduct a robustness study for SPC-15 delivery

TIPRANKS
·
Jun 30

Silo Pharma Launches Drug-device Robustness Study for Spc-15 PTSD Nasal Spray System

Reuters
·
Jun 30

Silo Pharma - Data to Support Planned FDA Type C Meeting Request for Ind Strategy and Phase 1 Design

THOMSON REUTERS
·
Jun 30

Silo Pharma - Robustness Study to Evaluate Spc-15 Device Performance and Formulation Stability over 30 Days

THOMSON REUTERS
·
Jun 30

Silo Pharma - Engages Resyca for Robustness Study of Spc-15 Nasal Spray System

THOMSON REUTERS
·
Jun 30

Silo Pharma reports positive stability data for stress treatment SPC-15

TIPRANKS
·
Jun 23

Silo Pharma reports SPC-15 PTSD nasal spray shows nine-month stability, supports Phase 1 trial plan

Reuters
·
Jun 23

Silo Pharma Reports Positive Stability Data for Spc-15 Ptsd Treatment, Advancing Program Toward First-in-Human Clinical Trial

THOMSON REUTERS
·
Jun 23

The loneliness crisis has gotten so bad that lawmakers are ready to spend millions of dollars to fight it

Dow Jones
·
Jun 22

The loneliness crisis has gotten so bad that lawmakers are ready to spend millions of dollars to fight it

Dow Jones
·
Jun 19

Silo Pharma announces annual shareholder meeting

Reuters
·
Jun 19

Silo Pharma Says it Regained Compliance With Nasdaq's Minimum Bid Price Requirement

MT Newswires Live
·
Jun 18

Silo Pharma regains Nasdaq compliance with minimum bid price rule

Reuters
·
Jun 18

Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS
·
Jun 18